Lundbeckfond Invest A/S
SEC CIK 1591046 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics, Inc. | 10% | 1.32M | $2.50M | — | 2 | 2023-11-07 | 2023-11-07 |
Most active insiders at LXEO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Townsend Richard Nolan | CEO, Dir | — | $655.7K |
| 2 | Bhalla Narinder Pal | Chief Medical Off | — | $98.6K |
| 3 | Otero Jose Manuel | Chief Technical Off | — | $78.9K |
| 4 | Tamayo Louis Edward | CFO | — | $41.0K |
| 5 | See Tai Sandi | Chief Development Off | — | $38.4K |
| 6 | Robertson Jenny | CLO | — | $36.6K |
| 7 | Adler Eric | Chief Medical Off | — | $36.0K |
Lundbeckfond Invest A/S made no open-market trades at LXEO in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-11-09 | 2023-11-07 | LXEO | Lexeo Therapeutics, Inc. | Lundbeckfond Invest A/S | 10% | C - Cnv Deriv | — | +1.61M | 1.32M | New | — |
| D | 2023-11-09 | 2023-11-07 | LXEO | Lexeo Therapeutics, Inc. | Lundbeckfond Invest A/S | 10% | P - Purchase | $11.00 | +227.3K | 1.84M | +14% | +$2.50M |
Purchase Sale Sale after option exercise All abbreviations